Skip to main content
Fig. 4 | Pilot and Feasibility Studies

Fig. 4

From: Prophylaxis of acute respiratory infections via improving the immune system in late preterm newborns with E. coli strain Nissle 1917: a controlled pilot trial

Fig. 4

Exploratory results of secondary efficacy measures. Shown are the mean numbers of ARIs (a), the mean numbers of hospitalizations due to ARIs (b), and the mean durations of hospitalizations due to ARIs (c) after 28 days, 6 months, and 12 months for the EcN and the control group, respectively. Error bars represent 95% confidence intervals. As statistical analyses of secondary efficacy variables are only performed for explorative purposes, given p values are not corrected for α-error inflation

Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784